good natured Products - CEO, Paul Antoniadis.
CEO, Paul Antoniadis.
Source: YouTube.
  • good natured Products (GDNP) has announced a non-brokered private placement for gross proceeds up to $6 million
  • The company will issue up to 15,000,000 warrants at a price of $0.40 per warrant
  • Each warrant will be converted into one unit four months following the closing of the offering
  • The net proceeds of the offering will be used primarily to fund the acquisition of FormTex Plastics Inc.
  • good natured Products is focused on becoming North America’s leading earth-friendly plant-based products company
  • good natured Products Inc. (GDNP) opened trading at C$0.41 per share

good natured Products (GDNP) has announced a non-brokered private placement for gross proceeds up to $6 million.

The company will issue up to 15,000,000 warrants at a price of $0.40 per warrant.

Each warrant will be converted into one unit four months following the closing of the offering. Each unit will consist of one common share and one half of one common share purchase warrant. Each full warrant will entitle the holder to acquire one additional common share at a price of $0.52 for a period of 24 months.

The warrants are subject to acceleration clause.

The net proceeds of the offering will be used primarily to fund the acquisition of FormTex Plastics Inc. The offering is subject to approval from the TSX Venture Exchange.

good natured Products is focused on becoming North America’s leading earth-friendly plant-based products company.

good natured Products Inc. (GDNP) opened trading at C$0.41 per share.

More From The Market Online

“Paw Patrol” owners see a 52-week share price high

Spin Master (TSX:TOY) reported 8.9 per cent revenue growth to US$436.4 million and returned to profitability.

Uber Eats expands grocery delivery network with new U.S. regional retail partners

Uber (NYSE:UBER) Eats added Busch’s Fresh Food Market, Hays, and Lowe’s Market to its grocery delivery marketplace across the U.S.

Cybersecurity stocks worth watching as digital risks continue to evolve

Cybersecurity threats continue to evolve, while recent disruptions highlighted the importance of resilient digital infrastructure.

A small-cap contender looking to challenge the weight-loss drug giants

Structure Therapeutics (NASDAQ:GPCR) is developing an oral weight-loss pill that could offer an alternative to popular injectable treatments.